Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Zi Yuan Zou"'
Autor:
Zi-Yuan Zou1, Jing Zeng1, Tian-Yi Ren1, Lei-Jie Huang1, Meng-Yu Wang1, Yi-Wen Shi1, Rui-Xu Yang1, Qian-Ren Zhang1, Jian-Gao Fan1 fanjiangao@xinhuamed.com.cn
Publikováno v:
Liver International. Aug2022, Vol. 42 Issue 9, p1969-1980. 12p.
Autor:
Zi-Yuan Zou, Tian-Yi Ren, Jia-Qi Li, Ting-Ying Jiao, Meng-Yu Wang, Lei-Jie Huang, Shuang-Zhe Lin, Yuan-Yang Wang, Xiao-Zhen Guo, Ye-Yu Song, Rui-Xu Yang, Cen Xie, Jian-Gao Fan
Publikováno v:
Journal of Clinical & Translational Hepatology; Sep2024, Vol. 12 Issue 9, p765-779, 15p
Autor:
Yan Song, Pei-Mei Shi, Wei-Fen Xie, Zi-Yuan Zou, Yi-Bin Guo, Zong-Li Yuan, Ping-Fang Hu, Xin Zeng, Yong-Quan Shi, Yu Tan, Tang Wei
Publikováno v:
Hepatobiliary Surg Nutr
BACKGROUND: With lifestyle modification and over-nutrition, the prevalence of nonalcoholic fatty liver disease (NAFLD) has been increasing annually. Here we aimed to assess the updated prevalence of NAFLD, and to evaluate the association of NAFLD wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da2abc874e9efd9f9520de531aad4a24
https://doi.org/10.21037/hbsn-20-263
https://doi.org/10.21037/hbsn-20-263
Autor:
Jing Zeng, Tian-Yi Ren, Jian-Gao Fan, Rui-Xu Yang, Lei-Jie Huang, Qian-Ren Zhang, Zi-Yuan Zou, Meng-Yu Wang, Yi-Wen Shi
Publikováno v:
Liver International. 42:1969-1980
BACKGROUND Despite substantial attention paid to the epidemic of nonalcoholic fatty liver disease (NAFLD) in adults, data on the burden and sexual dimorphism of NAFLD in Asian children have not yet been synthesized. METHODS We conducted a literature
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::baf75c14c2967502398de671e1a25da9
https://doi.org/10.1111/liv.15080
https://doi.org/10.1111/liv.15080
Autor:
Jing Wang, Huabao Liu, Li Jiang, Qing-Hua Long, Lin Tan, Xiujuan Chang, Zujiang Yu, Yongping Yang, Yi-Wen Shi, Xiao-Ning Zhu, Qin Li, Qinghua Shang, Linjing An, Xiaoyu Hu, Liang Chen, Vincent Wai-Sun Wong, Jian-Gao Fan, Yong-Ping Chen, Wei Lu, Zi-Yuan Zou, Guangming Xiao, Yan Chen
Publikováno v:
Hepatobiliary & Pancreatic Diseases International. 20:416-425
Although concomitant nonalcoholic steatohepatitis (NASH) is common in chronic hepatitis B (CHB), the impact of viral factors on NASH and the outcome of CHB patients concomitant with NASH remain unclear. We aimed to investigate the outcomes of NASH in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a68584ee05b529e1817b9e1a9151fe0
https://doi.org/10.1016/j.hbpd.2021.06.009
https://doi.org/10.1016/j.hbpd.2021.06.009
Publikováno v:
Journal of Digestive Diseases. 22:680-682
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cef9e6e2c57cac673e15009367130f7f
https://doi.org/10.1111/1751-2980.13060
https://doi.org/10.1111/1751-2980.13060
Autor:
Jing Zeng, Feng Shen, Zi-Yuan Zou, Rui-Xu Yang, Qian Jin, Jing Yang, Guang-Yu Chen, Jian-Gao Fan
Publikováno v:
World journal of gastroenterology. 28(16)
Childhood obesity and fatty liver are associated with adverse outcomes such as diabetes, metabolic syndrome, and cardiovascular diseases in adulthood. It is very important to identify relevant risk factors and intervene as early as possible. At prese
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e8dd24d8644c4289bab9b03830c93d2
https://pubmed.ncbi.nlm.nih.gov/35581961
https://pubmed.ncbi.nlm.nih.gov/35581961
Publikováno v:
Journal of digestive diseasesREFERENCES. 21(7)
Objective As a subgroup of nonalcoholic fatty liver disease (NAFLD), patients with non-obese NAFLD may also have an increased risk of adverse hepatic and metabolic outcomes. We aimed to estimate the prevalence and incidence of non-obese NAFLD and to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdabc6d37d13cef867233ddffeb5a8b6
https://pubmed.ncbi.nlm.nih.gov/32369237
https://pubmed.ncbi.nlm.nih.gov/32369237
Publikováno v:
SSRN Electronic Journal.
Background & Aims: As a subpopulation of nonalcoholic fatty liver disease (NAFLD), non-obese NAFLD may also have increased risk of adverse hepatic and metabolic outcomes. We estimated the prevalence of non-obese NAFLD and described its clinical chara
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c512513c3cab72a3b30611ef1abc604d
https://doi.org/10.2139/ssrn.3436278
https://doi.org/10.2139/ssrn.3436278
Publikováno v:
Journal of Clinical and Translational Hepatology
Background and Aims Nonalcoholic fatty liver disease, now renamed metabolic dysfunction-associated fatty liver disease (MAFLD), is common in obese patients. Intragastric balloon (IGB), an obesity management tool with low complication risk, might be u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4026542e9bcfb22bc341a675d891f89e
https://doi.org/10.14218/jcth.2020.00183
https://doi.org/10.14218/jcth.2020.00183